Abstract |
Bcl-2 proteins are over-expressed in many tumors and are critically important for cell survival. Their anti-apoptotic activities are determined by intracellular localization and post-translational modifications (such as phosphorylation). Here, we showed that WAVE1, a member of the Wiskott-Aldrich syndrome protein family, was over-expressed in blood cancer cell lines, and functioned as a negative regulator of apoptosis. Further enhanced expression of WAVE1 by gene transfection rendered leukemia cells more resistant to anti- cancer drug-induced apoptosis; whereas suppression of WAVE1 expression by RNA interference restored leukemia cells' sensitivity to anti- drug-induced apoptosis. WAVE1 was found to be associated with mitochondrial Bcl-2, and its depletion led to mitochondrial release of Bcl-2, and phosphorylation of ASK1/JNK and Bcl-2. Furthermore, depletion of WAVE1 expression increased anti- cancer drug-induced production of reactive oxygen species in leukemia cells. Taken together, these results suggest WAVE1 as a novel regulator of apoptosis, and potential drug target for therapeutic intervention of leukemia.
|
Authors | R Kang, D Tang, Y Yu, Z Wang, T Hu, H Wang, L Cao |
Journal | Leukemia
(Leukemia)
Vol. 24
Issue 1
Pg. 177-86
(Jan 2010)
ISSN: 1476-5551 [Electronic] England |
PMID | 19890377
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- BCL2L1 protein, human
- Proto-Oncogene Proteins c-bcl-2
- Reactive Oxygen Species
- WASF1 protein, human
- Wiskott-Aldrich Syndrome Protein Family
- bcl-X Protein
- MAP Kinase Kinase Kinase 5
- MAP3K5 protein, human
- Calcium
|
Topics |
- Apoptosis
- Calcium
(metabolism)
- Cell Line, Tumor
- Humans
- Leukemia
(drug therapy, metabolism)
- MAP Kinase Kinase Kinase 5
(physiology)
- Phosphorylation
- Proto-Oncogene Proteins c-bcl-2
(metabolism)
- Reactive Oxygen Species
(metabolism)
- Wiskott-Aldrich Syndrome Protein Family
(analysis, physiology)
- bcl-X Protein
(metabolism)
|